The beta-adrenergic blocking agents and the treatment of glaucoma
- PMID: 37605
- DOI: 10.1016/0039-6257(79)90228-5
The beta-adrenergic blocking agents and the treatment of glaucoma
Abstract
The autonomic nervous system is divided into the parasympathetic and sympathetic systems, with three types of adrenergic receptors: alpha (smooth muscle contraction), beta1 (cardiac acceleration and fatty acid mobilization) and beta2 (smooth muscle relaxation). Substances affecting the function of the adrenergic system are the agonists or stimulators, which mimic the effects of endogenous norepinephrine or epinephrine, and antagonists or blockers, which block the receptors and prevent stimulation by the agonists. Autonomic stimulation in the eye mediates various changes which apparently affect outflow facility and rate of formation of aqueous humor. Alteration of either or both of these factors by autonomic agonists or antagonists may have a direct or an indirect effect on intraocular pressure. Beta-adrenergic blocking substances have been used to treat a variety of diseases. Some of the effects of these drugs are attributable to properties other than beta blockade, such as intrinsic sympathomimetic activity and local anaesthetic activity. Side effects of this class of drugs require caution in cases of congestive heart failure and in asthmatics. Autonomic agents used in the treatment of ocular hypertension and glaucoma include pilocarpine, a chilinergic agonist, epinephrine, an adrenergic agonist, and various beta adrenergic blockers or antagonists including propranolol, atenolol and timolol. The physico-chemical properties and pharmacokinetics of timolol are reviewed. Data showing a significant reduction in intraocular pressure as a result of ocular instillation of timolol are presented. Reduction of the rate of aqueous formation appears to be the mechanism of action. A low incidence of non-serious side effects is reported.
Similar articles
-
Timolol in the therapy of "ocular hypertension".Surv Ophthalmol. 1980 Nov-Dec;25(3):195-202. doi: 10.1016/0039-6257(80)90098-3. Surv Ophthalmol. 1980. PMID: 6110245
-
Effects of D-timolol on intraocular pressure (IOP), beta blocking activity, and the dynamic changes of drug concentrations in aqueous humor.J Ocul Pharmacol. 1989 Winter;5(4):271-9. doi: 10.1089/jop.1989.5.271. J Ocul Pharmacol. 1989. PMID: 2576432 Clinical Trial.
-
[Timolol maleate. Pharmacology and review of the literature].Can J Ophthalmol. 1979 Jul;14(3):208-14. Can J Ophthalmol. 1979. PMID: 487260 French.
-
Comparison of ophthalmic beta-blocking agents.Clin Pharm. 1987 Jun;6(6):451-63. Clin Pharm. 1987. PMID: 2891463 Review.
-
Experimental studies on the mechanism of action of timolol.Surv Ophthalmol. 1979 May-Jun;23(6):363-70. doi: 10.1016/0039-6257(79)90229-7. Surv Ophthalmol. 1979. PMID: 223248 Review.
Cited by
-
Musical auditory stimulus acutely influences heart rate dynamic responses to medication in subjects with well-controlled hypertension.Sci Rep. 2018 Jan 17;8(1):958. doi: 10.1038/s41598-018-19418-7. Sci Rep. 2018. PMID: 29343839 Free PMC article.
-
Effect of pindolol on intraocular pressure in glaucoma: pilot study and a randomised comparison with timolol.Br J Ophthalmol. 1983 Apr;67(4):228-30. doi: 10.1136/bjo.67.4.228. Br J Ophthalmol. 1983. PMID: 6338906 Free PMC article. Clinical Trial.
-
Pharmacogenetics of ophthalmic topical beta-blockers.Per Med. 2008;5(4):377-385. doi: 10.2217/17410541.5.4.377. Per Med. 2008. PMID: 19266054 Free PMC article.
-
Ocular beta-blockers in glaucoma management. Clinical pharmacological aspects.Drugs Aging. 1992 May-Jun;2(3):208-21. doi: 10.2165/00002512-199202030-00005. Drugs Aging. 1992. PMID: 1351412 Review.
-
The Importance of Medicinal Chemistry Knowledge in the Clinical Pharmacist's Education.Am J Pharm Educ. 2018 Mar;82(2):6083. doi: 10.5688/ajpe6083. Am J Pharm Educ. 2018. PMID: 29606703 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources